<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pharmjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Разработка и регистрация лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Drug development &amp; registration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-2066</issn><issn pub-type="epub">2658-5049</issn><publisher><publisher-name>LLC «CPHA»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">pharmjournal-314</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФАРМАЦЕВТИЧЕСКАЯ ТЕХНОЛОГИЯ И НАНОТЕХНОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PHARMACEUTICAL TECHNOLOGY AND NANOTECHNOLOGY</subject></subj-group></article-categories><title-group><article-title>РЕГУЛИРОВАНИЕ ВЫСВОБОЖДЕНИЯ ИБУПРОФЕНА ИЗ МАТРИЧНЫХ ТАБЛЕТОК НА ОСНОВЕ КАРБОПОЛА</article-title><trans-title-group xml:lang="en"><trans-title>REGULATION OF IBUPROFEN RELEASE RATE FROM MATRIX TABLETS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Филиппова</surname><given-names>Н. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Filippova</surname><given-names>N. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вайнштейн</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vainshtein</surname><given-names>V. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сон</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Son</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Минина</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Minina</surname><given-names>S. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Санкт-Петербургская государственная химико-фармацевтическая академия» Министерства здравоохранения Российской Федерации</institution></aff><aff xml:lang="en"><institution>Saint-Petersburg State Chemical-Pharmaceutical Academy</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>09</day><month>01</month><year>2019</year></pub-date><volume>0</volume><issue>1</issue><fpage>58</fpage><lpage>64</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Филиппова Н.И., Вайнштейн В.А., Сон А.В., Минина С.А., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Филиппова Н.И., Вайнштейн В.А., Сон А.В., Минина С.А.</copyright-holder><copyright-holder xml:lang="en">Filippova N.I., Vainshtein V.A., Son A.V., Minina S.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmjournal.ru/jour/article/view/314">https://www.pharmjournal.ru/jour/article/view/314</self-uri><abstract><p>Исследованы профили высвобождения ибупрофена из таблеток в средах, имитирующих изменение рН в желудочно-кишечном тракте (ЖКТ). В качестве полимера-пролонгатора использовали карбопол Ультрез-21. Составы с тремя различными нейтрализующими агентами (L-лизин, N-метилглюкозамин, гидрокарбонат натрия) в различных соотношениях карбопол : нейтрализующий агент прессовали в таблетки с использованием метода влажной грануляции. В составах с гидрокарбонатом натрия наблюдалось наиболее быстрое высвобождение ибупрофена по сравнению с составами, в которых в качестве нейтрализующего агента использовались аминосодержащие L-лизин и N-метилглюкозамин. На скорость и степень высвобождения ибупрофена из таблеток существенно влияют количество и скорость нейтрализации карбопола. Скорость набухания карбопола возрастает с увеличением содержания нейтрализующего агента в составе таблеток.</p></abstract><trans-abstract xml:lang="en"><p>Release profiles were investigated from tablets of ibuprofen in media simulating the conditions of the gastrointestinal tract. Carbopol Ultrez 21 was used as prolongator polymer. The formulations with three different neutralizing agents [L-lysine, N-methylglucosamine (MGA), sodium hydrocarbonate] in several carbopol : neutralizer ratios were tabletted with using the wet granulation method. Faster release of ibuprofen has been observed in formulations with sodium hydrocarbonate, than in formulations with amine containing L-lysine and MGA. Both the amount and neutralization rate of carbopol influence significantly on rate and extent of ibuprofen release from tablets. Carbopol swelling rate grows up with increasing of neutralizer content in tablet.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>матричные таблетки</kwd><kwd>замедленное высвобождение</kwd><kwd>ибупрофен</kwd><kwd>карбопол</kwd><kwd>L-лизин</kwd><kwd>N-метилглюкозамин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>matrix tablets</kwd><kwd>sustained-release</kwd><kwd>ibuprofen</kwd><kwd>carbopol</kwd><kwd>L-lysine</kwd><kwd>MGA</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">T.E. Morozova, T.B. Andrushchishina, E.K. Antipova. Ibuprofen: bezopasnost' i effektivnost' primeneniya v shirokoi klinicheskoi praktike // Terapevticheskii arkhiv. 2013. № 3. S. 118-124.</mixed-citation><mixed-citation xml:lang="en">T.E. Morozova, T.B. Andrushchishina, E.K. Antipova. Ibuprofen: bezopasnost' i effektivnost' primeneniya v shirokoi klinicheskoi praktike // Terapevticheskii arkhiv. 2013. № 3. S. 118-124.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">M.V. Zhuravleva, A.Yu. Obzherina. Aktual'nye voprosy povysheniya bezopasnosti primeneniya nesteroidnykh protivovospalitel'nykh preparatov: znachenie farmakogeneticheskikh issledovanii // Vedomosti nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya. 2011. № 2. S. 31-34.</mixed-citation><mixed-citation xml:lang="en">M.V. Zhuravleva, A.Yu. Obzherina. Aktual'nye voprosy povysheniya bezopasnosti primeneniya nesteroidnykh protivovospalitel'nykh preparatov: znachenie farmakogeneticheskikh issledovanii // Vedomosti nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya. 2011. № 2. S. 31-34.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">D. Bhowmik, H. Gopinath, B. Pragati Kumar, S. Duraival, K.P. Sampath Kumar. Controlled Release drug delivery system // The Pharma innovation. 2012. V. 1. P. 322-324.</mixed-citation><mixed-citation xml:lang="en">D. Bhowmik, H. Gopinath, B. Pragati Kumar, S. Duraival, K.P. Sampath Kumar. Controlled Release drug delivery system // The Pharma innovation. 2012. V. 1. P. 322-324.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">I. Chugh, N. Seth, A.C. Rana, S. Gupta. Oral sustained release drug delivery system: anoverview // International research journal of pharmacy. 2012. V. 3(5). P. 57-62.</mixed-citation><mixed-citation xml:lang="en">I. Chugh, N. Seth, A.C. Rana, S. Gupta. Oral sustained release drug delivery system: anoverview // International research journal of pharmacy. 2012. V. 3(5). P. 57-62.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">E. Jantratid et al. Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update // Pharm. Res. 2008. V 25(7). P. 1663-1676.</mixed-citation><mixed-citation xml:lang="en">E. Jantratid et al. Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update // Pharm. Res. 2008. V 25(7). P. 1663-1676.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">I.E. Smekhova, Yu.M. Perova, I.A. Kondrat'eva, A.N. Rodygina, N.N. Turetskova. Test «Rastvorenie» i sovremennye podkhody k otsenke ekvivalentnosti lekarstvennykh preparatov (obzor) // Razrabotka i registratsiya lekarstvennykh sredstv. 2013. № 1(2). S. 26-30.</mixed-citation><mixed-citation xml:lang="en">I.E. Smekhova, Yu.M. Perova, I.A. Kondrat'eva, A.N. Rodygina, N.N. Turetskova. Test «Rastvorenie» i sovremennye podkhody k otsenke ekvivalentnosti lekarstvennykh preparatov (obzor) // Razrabotka i registratsiya lekarstvennykh sredstv. 2013. № 1(2). S. 26-30.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">N.B. Demina. Sovremennye tendentsii razvitiya tekhnologii matrichnykh lekarstvennykh form s modifitsirovannym vysvobozhdeniem (obzor) // Khimiko-farmatsevticheskii zhurnal. 2016. T. 50. № 7. S. 74-80.</mixed-citation><mixed-citation xml:lang="en">N.B. Demina. Sovremennye tendentsii razvitiya tekhnologii matrichnykh lekarstvennykh form s modifitsirovannym vysvobozhdeniem (obzor) // Khimiko-farmatsevticheskii zhurnal. 2016. T. 50. № 7. S. 74-80.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">J. Jinno, D.M. Oh, J.R. Crison, G.L. Amidon. Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant // Journal of Pharmaceutical Sciences. 2000. V. 89(2). P. 268-274.</mixed-citation><mixed-citation xml:lang="en">J. Jinno, D.M. Oh, J.R. Crison, G.L. Amidon. Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant // Journal of Pharmaceutical Sciences. 2000. V. 89(2). P. 268-274.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">K.A. Watkins, R. Chen. pH-responsive, lysine-based hydrogels for the oral delivery of a wide 2 size range of molecules // Int. J. Pharm. 2014. V. 464. P. 10-18</mixed-citation><mixed-citation xml:lang="en">K.A. Watkins, R. Chen. pH-responsive, lysine-based hydrogels for the oral delivery of a wide 2 size range of molecules // Int. J. Pharm. 2014. V. 464. P. 10-18</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
